The Health Service Medical Supplies (Costs) Act 2017 (c. 23) is an act of the Parliament of the United Kingdom.
Background Pharmaceutical companies were accused of charging extremely high prices for certain drugs in reporting in the Times.
At the time of the passage of the act, the National Health Service spent on medicines and medicinal supplies.
Provisions It provides that pharmaceutical companies can be compelled to reduce the price of a generic medicine or introduce other controls on branded products in cases where charges are "unreasonable".
The act requires that access patient access be considered in the way drugs are priced.
Notes
References
External links